|1.||Shi, Bei: 2 articles (03/2014 - 08/2012)|
|2.||Yamamoto, Hiroshi: 2 articles (01/2012 - 07/2011)|
|3.||Mikami, Norihisa: 2 articles (01/2012 - 07/2011)|
|4.||Fukada, So-ichiro: 2 articles (01/2012 - 07/2011)|
|5.||Tsujikawa, Kazutake: 2 articles (01/2012 - 07/2011)|
|6.||Zhang, Zhongming: 2 articles (03/2010 - 07/2009)|
|7.||Russo, Andrew F: 2 articles (03/2010 - 07/2009)|
|8.||Tang, Wenjing: 1 article (01/2015)|
|9.||Yu, Shengyuan: 1 article (01/2015)|
|10.||Liu, Ruozhuo: 1 article (01/2015)|
|1.||Migraine Disorders (Migraine)
07/08/2009 - "Our findings demonstrate that a single gene, receptor activity-modifying protein 1 (RAMP1), can be a modifier of photophobia and, by extension, suggest that genetic or epigenetic modulation of RAMP1 levels may contribute to migraine susceptibility. "
02/15/2013 - "This study investigates whether variants in the gene that encodes CGRP, calcitonin-related polypeptide alpha (CALCA) or in the gene that encodes a component of its receptor, receptor activity modifying protein 1 (RAMP1), are associated with migraine pathogenesis and susceptibility. "
01/01/2015 - "Receptor activity modifying protein 1(RAMP1) is a key receptor subunit of calcitonin gene related peptide (CGRP) playing a critical role in migraine. "
05/01/2011 - "CGRP, an important mediator of migraine pathogenesis, and the 3 components of its receptor, calcitonin-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and receptor component protein (RCP) mRNAs were quantified in the trigeminal ganglion and medulla to identify baseline sex differences and changes associated with application of IS or PBS to the dura. "
04/01/2005 - "The present study was designed to investigate the expression of CGRP receptor components, calcitonin receptor-like receptor (CRLR), and receptor activity modifying protein 1 (RAMP1), and the relaxation response to CGRP in fetoplacental vessels from normotensive pregnant women and women with preeclampsia. "
03/01/2009 - "To determine placental gene expression of calcitonin gene-related peptide (CGRP), calcitonin receptor-like receptor (CRLR), receptor activity modifying protein 1 (RAMP1), and endothelial and inducible nitric oxide synthases (eNOS and iNOS) in mild preeclampsia, and to assess the effects of magnesium sulfate (MgSO4). "
01/01/2012 - "CGRP binds to CGRP receptors composed of receptor activity-modifying protein 1 (RAMP1) and calcitonin receptor-like receptor (CLR) to modulate various functions such as pain transmission and vasodilation. "
06/07/2013 - "Although the release of CGRP is well observed in pain-related regions after chronic morphine treatment, a lack of evidence is obvious for the expression of CGRP-receptor subunits, calcitonin receptor-like receptor (CRLR) and receptor activity-modifying protein 1 (RAMP1) in the brain. "
08/14/2012 - "To observe the effects of mesenchymal stem cells (MSC) modified by human receptor activity-modifying protein 1 (hRAMP1) on restenosis and cardiac function post-myocardial infarction (MI) and explore the therapeutic safety for gene modification of MSC. "
03/01/2014 - "Here, we investigated the effects of MSCs overexpressing the human receptor activity-modifying protein 1 (hRAMP1) on heart function and artery repair in rabbit models of myocardial infarction (MI) reperfusion and carotid artery injury. "
03/01/2014 - "Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model."
|5.||Photophobia (Light Sensitivity)
|1.||Calcitonin Receptor-Like Protein
|2.||Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)
|3.||Calcitonin (Calcitonin, Eel)
|4.||Calcitonin Gene-Related Peptide
|6.||LDL-Receptor Related Protein 1 (LDL-Receptor Related Protein)
|7.||Calcitonin Receptors (Calcitonin Receptor)
|8.||Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
|9.||Oxidopamine (6 Hydroxydopamine)
|1.||Angioplasty (Angioplasty, Transluminal)
|2.||Transplantation (Transplant Recipients)